Jiangxi Institute of Biological Products Inc. (HKG:6915)
Hong Kong · Delayed Price · Currency is HKD 10.74
+0.45 (4.37%)
At close: Oct 7, 2026
HKG:6915 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Net Income | 72.32 | 94.79 | 75.14 | 55.49 |
Depreciation & Amortization | 13.38 | 13.18 | 13.22 | 12.24 |
Other Amortization | 0.12 | 0.12 | 0.12 | 0.12 |
Loss (Gain) From Sale of Assets | -3.76 | -3.76 | 0.03 | -0.06 |
Asset Writedown & Restructuring Costs | -14.01 | -14.01 | -2.7 | -1.09 |
Loss (Gain) From Sale of Investments | -0.13 | -0.13 | -0.11 | -0.26 |
Provision & Write-off of Bad Debts | 2.49 | 2.49 | -0.12 | -0.33 |
Other Operating Activities | 30.95 | 2.72 | 26.87 | -0.68 |
Change in Accounts Receivable | -37.68 | -37.68 | 5.71 | -11.25 |
Change in Inventory | 10.86 | 10.86 | -4.5 | 10.1 |
Change in Accounts Payable | -5.92 | -5.92 | -6.74 | 4.65 |
Change in Unearned Revenue | -0.51 | -0.51 | -0.65 | -2.15 |
Change in Other Net Operating Assets | -5.32 | -5.32 | -2.21 | 1.84 |
Operating Cash Flow | 62.78 | 56.83 | 104.06 | 68.61 |
Operating Cash Flow Growth | - | -45.39% | 51.67% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Capital Expenditures | -33.4 | -36.04 | -16.64 | -30.42 |
Sale of Property, Plant & Equipment | 3.38 | 2.97 | 4.35 | 6.4 |
Divestitures | - | 5.36 | - | - |
Sale (Purchase) of Intangibles | - | - | -20 | - |
Sale (Purchase) of Real Estate | - | - | - | -4.4 |
Investment in Securities | 0.74 | 4.24 | -4 | 27.26 |
Other Investing Activities | - | -1.56 | 20 | 0.13 |
Investing Cash Flow | -29.28 | -25.03 | -16.3 | -1.04 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Short-Term Debt Issued | - | - | 8.5 | 29.9 |
Total Debt Issued | - | - | 8.5 | 29.9 |
Short-Term Debt Repaid | - | - | -28.4 | -47.6 |
Long-Term Debt Repaid | - | -0.07 | -3.14 | -0.32 |
Lease Payments | -0.27 | -0.07 | -3.14 | -0.32 |
Total Debt Repaid | -0.27 | -0.07 | -31.54 | -47.92 |
Net Debt Issued (Repaid) | -0.27 | -0.07 | -23.04 | -18.02 |
Common Dividends Paid | - | - | -40.82 | -86.18 |
Other Financing Activities | -18.43 | -12.56 | -27.49 | 40.91 |
Financing Cash Flow | 333.8 | -12.62 | -91.35 | -63.29 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Foreign Exchange Rate Adjustments | -0.02 | -0.02 | 0.07 | 0.09 |
Net Cash Flow | 367.28 | 19.16 | -3.53 | 4.37 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | 29.39 | 20.79 | 87.41 | 38.19 |
Free Cash Flow Growth | - | -76.22% | 128.91% | - |
Free Cash Flow Margin | 13.42% | 8.83% | 39.60% | 19.28% |
Free Cash Flow Per Share | 0.11 | 0.08 | 0.32 | 0.14 |
Levered Free Cash Flow | - | -30.65 | -7.81 | - |
Unlevered Free Cash Flow | - | -30.63 | -6.42 | - |
Free Cash Flow After Leases | 29.12 | 20.72 | 84.27 | 37.87 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash Interest Paid | 0.01 | 0.01 | 2.25 | 0.67 |
Cash Income Tax Paid | 14.03 | 14.03 | 8.34 | 12.69 |
Change in Working Capital | -38.57 | -38.57 | -8.39 | 3.19 |